BALYASNY ASSET MANAGEMENT L.P. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 89 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$208,612
+293.6%
17,341
+49.1%
0.00%
Q2 2022$53,000
-82.9%
11,627
-46.4%
0.00%
-100.0%
Q4 2021$310,00021,6870.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders